OncoSec Medical Inc (ONCS.OQ)
ONCS.OQ on NASDAQ Stock Exchange Capital Market
1.57USD
20 Apr 2018
1.57USD
20 Apr 2018
Change (% chg)
$-0.09 (-5.42%)
$-0.09 (-5.42%)
Prev Close
$1.66
$1.66
Open
$1.63
$1.63
Day's High
$1.65
$1.65
Day's Low
$1.56
$1.56
Volume
259,290
259,290
Avg. Vol
170,723
170,723
52-wk High
$2.95
$2.95
52-wk Low
$0.88
$0.88
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.19 | July | 21 Apr 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 4 | 3 | 3 | 3 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Jul-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Jul-19 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Jan-18 | 3 | -0.19 | -0.16 | -0.21 | -- |
| Quarter Ending Apr-18 | 1 | -0.19 | -0.19 | -0.19 | -0.22 |
| Year Ending Jul-18 | 2 | -0.70 | -0.60 | -0.80 | -0.99 |
| Year Ending Jul-19 | 2 | -0.71 | -0.60 | -0.82 | -0.88 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jan-18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jul-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Apr-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jan-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Oct-16 | 0.00 | 0.00 | 0.00 | 0.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-18 | 0.00 | -- | -- | -- | -- |
| Year Ending Jul-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Jul-19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jan-18 | -- | -- | -- | -- |
| Year Ending Jul-18 | 0 | 0 | 0 | 0 |
| Year Ending Jul-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
Earnings vs. 
Estimates- BRIEF-Oncosec Medical Prices $20 Mln Public Offering Of Common Stock
- BRIEF-OncoSec Medical Announces Proposed Public Offering Of Common Stock
- BRIEF-OncoSec Provides Encouraging Clinical Observations Related To Triple Negative Breast Cancer Study
- BRIEF-Oncosec Plans To Conduct A Second Clinical Trial In Triple Negative Breast Cancer In 2018
- BRIEF-Oncosec Announces Dosing Of First Patient In Registration-Directed Phase 2B Clinical Trial